The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Hydroxyethyl Starch 130/0.42 versus Ringer's Acetate in Severe Sepsis
Abstract
BACKGROUND: Hydroxyethyl starch (HES) [corrected] is widely used for fluid resuscitation in intensive care units (ICUs), but its safety and efficacy have not been established in patients with severe sepsis. METHODS: In this multicenter, parallel-group, blinded trial, we randomly assigned patients with severe sepsis to fluid resuscitation in the ICU with either 6% HES 130/0.42 (Tetraspan) or Ringer's acetate at a dose of up to 33 ml per kilogram of ideal body weight per day. The primary outcome measure was either death or end-stage kidney failure (dependence on dialysis) at 90 days after randomization. RESULTS: Of the 804 patients who underwent randomization, 798 were included in the modified intention-to-treat population. The two intervention groups had similar baseline characteristics. At 90 days after randomization, 201 of 398 patients (51%) assigned to HES 130/0.42 had died, as compared with 172 of 400 patients (43%) assigned to Ringer's acetate (relative risk, 1.17; 95% confidence interval [CI], 1.01 to 1.36; P=0.03); 1 patient in each group had end-stage kidney failure. In the 90-day period, 87 patients (22%) assigned to HES 130/0.42 were treated with renal-replacement therapy versus 65 patients (16%) assigned to Ringer's acetate (relative risk, 1.35; 95% CI, 1.01 to 1.80; P=0.04), and 38 patients (10%) and 25 patients (6%), respectively, had severe bleeding (relative risk, 1.52; 95% CI, 0.94 to 2.48; P=0.09). The results were supported by multivariate analyses, with adjustment for known risk factors for death or acute kidney injury at baseline. CONCLUSIONS: Patients with severe sepsis assigned to fluid resuscitation with HES 130/0.42 had an increased risk of death at day 90 and were more likely to require renal-replacement therapy, as compared with those receiving Ringer's acetate. (Funded by the Danish Research Council and others; 6S ClinicalTrials.gov number, NCT00962156.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · Chest · doi:10.1378/chest.101.6.1644 · Cited by 13,198
Vincent, J. L., Moreno, R., Takala, J., Willatts, S., De Mendonça, A., Bruining, H., Reinhart, C. K., Suter, P. M., & Thijs, L. G. (1996) · Intensive Care Medicine · doi:10.1007/bf01709751 · Cited by 11,674
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31827e83af · Cited by 9,694
Le Gall, J.-R. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.270.24.2957 · Cited by 7,773
Bellomo, R., Ronco, C., Kellum, J. A., Mehta, R. L., Palevsky, P., & workgroup, T. A. (2004) · Critical Care · doi:10.1186/cc2872 · Cited by 6,781
Dellinger, R. P., Levy, M. M., Carlet, J. M., Bion, J., Parker, M. M., Jaeschke, R., Reinhart, K., Angus, D. C., Brun-Buisson, C., Beale, R., et al. (2008) · Intensive Care Medicine · doi:10.1007/s00134-007-0934-2 · Cited by 6,772
A Multicenter, Randomized, Controlled Clinical Trial of Transfusion Requirements in Critical Care
Hébert, P. C., Wells, G., Blajchman, M. A., Marshall, J., Martin, C., Pagliarello, G., Tweeddale, M., Schweitzer, I., & Yetisir, E. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400601 · Cited by 5,187
Intensive insulin therapy and pentastarch resuscitation in severe sepsis
Brunkhorst, F. M., Engel, C., Bloos, F., Meier-Hellmann, A., Ragaller, M., Weiler, N., Moerer, O., Gruendling, M., Oppert, M., Grond, S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa070716 · Cited by 2,921
A Comparison of Albumin and Saline for Fluid Resuscitation in the Intensive Care Unit
(2004) · New England Journal of Medicine · doi:10.1056/nejmoa040232 · Cited by 2,872
A Multicenter, Randomized, Controlled Clinical Trial of Transfusion Requirements in Critical Care
(1999) · New England Journal of Medicine · doi:10.1056/nejm199904013401322 · Cited by 2,037
Vasopressin versus Norepinephrine Infusion in Patients with Septic Shock
Russell, J. A., Walley, K. R., Singer, J., Gordon, A. C., Hébert, P. C., Cooper, D. J., Holmes, C. L., Mehta, S., Granton, J. T., Storms, M. M., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa067373 · Cited by 1,924
High-Dose Antithrombin III in Severe Sepsis: A Randomized Controlled Trial
Warren, B. L., Eid, A., Singer, P., Pillay, S. S., Carl, P., Novak, I., Chalupa, P., Atherstone, A., Pénzes, I., Kübler, A., et al. (2001) · JAMA · doi:10.1001/jama.286.15.1869 · Cited by 1,419
Colloids versus crystalloids for fluid resuscitation in critically ill patients
Perel, P., Roberts, I., & Ker, K. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000567.pub6 · Cited by 1,115
Septic Acute Kidney Injury in Critically Ill Patients: Clinical Characteristics and Outcomes
Bagshaw, S. M., Uchino, S., Bellomo, R., Morimatsu, H., Morgera, S., Schetz, M., Tan, I., Bouman, C., Macedo, E., Gibney, N., et al. (2007) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03681106 · Cited by 888
Schortgen, F., Lacherade, J.-C., Bruneel, F., Cattaneo, I., Hemery, F., Lemaire, F., & Brochard, L. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04211-2 · Cited by 741
Post-randomisation exclusions: the intention to treat principle and excluding patients from analysis
Fergusson, D., Aaron, S. D., Guyatt, G., & Hébert, P. (2002) · BMJ · doi:10.1136/bmj.325.7365.652 · Cited by 708
Impact of albumin compared to saline on organ function and mortality of patients with severe sepsis
The SAFE Study Investigators (2011) · Intensive Care Medicine · doi:10.1007/s00134-010-2039-6 · Cited by 399
Clermont, G., Acker, C. G., Angus, D. C., Sirio, C. A., Pinsky, M. R., & Johnson, J. P. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00509.x · Cited by 366
Guidet, B., Martinet, O., Boulain, T., Philippart, F., Poussel, J., Maizel, J., Forceville, X., Feissel, M., Hasselmann, M., Heininger, A., et al. (2012) · Critical Care · doi:10.1186/cc11358 · Cited by 344
Consensus statement of the ESICM task force on colloid volume therapy in critically ill patients
Reinhart, K., Perner, A., Sprung, C. L., Jaeschke, R., Schortgen, F., Johan Groeneveld, A. B., Beale, R., & Hartog, C. S. (2012) · Intensive Care Medicine · doi:10.1007/s00134-012-2472-9 · Cited by 282
Self-citationEffects of hydroxyethyl starch administration on renal function in critically ill patients
Sakr, Y., Payen, D., Reinhart, K., Sipmann, F. S., Zavala, E., Bewley, J., Marx, G., & Vincent, J.-L. (2007) · British Journal of Anaesthesia · doi:10.1093/bja/ael333 · Cited by 165
Renal Histopathological Lesions After Orthotopic Liver Transplantation (OLT)
Pillebout, E., Nochy, D., Hill, G., Conti, F., Antoine, C., Calmus, Y., & Glotz, D. (2005) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2005.00852.x · Cited by 161
Antithrombin III for critically ill patients
Allingstrup, M., Wetterslev, J., Ravn, F., Møller, A. M., & Afshari, A. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005370.pub3 · Cited by 127
Self-citationA Systematic Review of Third-Generation Hydroxyethyl Starch (HES 130/0.4) in Resuscitation
Hartog, C. S., Kohl, M., & Reinhart, K. (2011) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e31820ad607 · Cited by 126
Worsening of hepatic dysfunction as a consequence of repeated hydroxyethylstarch infusions
Christidis, C., Mal, F., Ramos, J., Sénéjoux, A., Callard, P., Navarro, R. P., Trinchet, J., Larrey, D. G., Beaugrand, M., & Guettier, C. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00200-8 · Cited by 92
Effect of Molecular Weight and Substitution on Tissue Uptake of Hydroxyethyl Starch
Bellmann, R., Feistritzer, C., & Wiedermann, C. J. (2012) · Clinical Pharmacokinetics · doi:10.2165/11594700-000000000-00000 · Cited by 87
the Scandinavian Critical Care Trials Group, Perner, A., Haase, N., Wetterslev, J., Åneman, A., Tenhunen, J. J., Guttormsen, A. B., Klemenzson, G., Pott, F. C., Bødker, K. D., et al. (2011) · Trials · doi:10.1186/1745-6215-12-24 · Cited by 64
Self-citationRenal Recovery after Severe Acute Renal Failure
Bagshaw, S. M., Mortis, G., Godinez-Luna, T., Doig, C., & Laupland, K. B. (2006) · The International Journal of Artificial Organs · doi:10.1177/039139880602901102 · Cited by 52
Hydrops lysosomalis generalisatus – an underestimated side effect of hydroxyethyl starch therapy?
Schmidt‐Hieber, M., Loddenkemper, C., Schwartz, S., Arntz, G., Thiel, E., & Notter, M. (2006) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2006.00657.x · Cited by 47
Preferences for colloid use in Scandinavian intensive care units
The FLUIDS study investigators for the Scandinavian Critical Care Trials Group (2008) · Acta Anaesthesiologica Scandinavica · doi:10.1111/j.1399-6576.2008.01690.x · Cited by 29
Are small hospitals with small intensive care units able to treat patients with severe sepsis?
Reinikainen, M., Karlsson, S., Varpula, T., Parviainen, I., Ruokonen, E., Varpula, M., Ala-Kokko, T. I., & Pettilä, V. (2010) · Intensive Care Medicine · doi:10.1007/s00134-009-1688-9 · Cited by 28
Initial fluid resuscitation of patients with septic shock in the intensive care unit
Carlsen, S., Perner, A., & for the East Danish Septic Shock Cohort Investigators (2011) · Acta Anaesthesiologica Scandinavica · doi:10.1111/j.1399-6576.2011.02399.x · Cited by 22
Self-citation
Cited by
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31827e83af · Cited by 9,694
The Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup*, Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., et al. (2013) · Intensive Care Medicine · doi:10.1007/s00134-012-2769-8 · Cited by 7,290
Intravenous Fluids and Acute Kidney Injury
Ding, X., Cheng, Z., & Qian, Q. (2017) · Blood Purification · doi:10.1159/000452702 · Cited by 6,827
Jakobsen, J. C., Gluud, C., Wetterslev, J., & Winkel, P. (2017) · BMC Medical Research Methodology · doi:10.1186/s12874-017-0442-1 · Cited by 2,747
Self-citationBellomo, R., Kellum, J. A., & Ronco, C. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61454-2 · Cited by 2,598
Metadata
- Authors
- Perner, A., Haase, N., Guttormsen, A. B., Tenhunen, J., Klemenzson, G., Åneman, A., Madsen, K. R., Møller, M. H., Elkjær, J. M., Poulsen, L. M., Bendtsen, A., Winding, R., Steensen, M., Berezowicz, P., Søe-Jensen, P., Bestle, M., Strand, K., Wiis, J., White, J. O., Thornberg, K. J., Quist, L., Nielsen, J., Andersen, L. H., Holst, L. B., Thormar, K., Kjældgaard, A.-L., Fabritius, M. L., Mondrup, F., Pott, F. C., Møller, T. P., Winkel, P., & Wetterslev, J.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2012-07-12
- Volume
- 367
- Issue
- 2
- Pages
- 124-134
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2132135347
- Cited by
- 1,813
- References
- 33
- FWCI
- 149.93
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.